ArticleAnnals of medicine2025

Identification of pyrimidine metabolism-based molecular subtypes and prognostic signature to predict immune landscape and guide clinical treatment in prostate cancer.

Yu-Zhong Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.